Antimicrobial resistance is a priority issue for all people
21 NOV - Urgen Voegele et al.,
Our bodies have provided a safe environment for thousands of species of microbes to flourish and in return microbes have provided us with many benefits – like protection against “bad” organisms and regulation of many of our physiological processes. We now know that a healthy, balanced microbiome is essential to human wellbeing. However, this coevolved synergy with microbes was never enough to avoid many infectious diseases which were often fatal, until the advent of modern antimicrobial drugs such as antibiotics that revolutionized human medicine in the 1940s. Since then, hundreds of millions of lives have been saved and economic development has accelerated with less human suffering and illness.
Access to Medicines Index highlights role of collaboration in stimulating R&D
21 NOV - The Index reports that every year, more than six million people in low- to middle-income countries die because the vaccines, medicines and diagnostic tests that they need are either ineffective or do not exist. The 2018 Index analysed how 20 of the world's largest pharmaceutical companies are addressing access to medicines in 106 countries for 77 diseases, conditions and pathogens.
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Ahead of print - Dimitrios Gouglas et al.,
Vaccines can be powerful tools for preventing potential outbreaks of epidemic infectious diseases from becoming humanitarian crises. Developing these vaccines requires investment. However, evidence on what it would cost to successfully develop a sound epidemic infectious disease vaccine portfolio is scarce. This is partly because of a paucity of explicit, publicly available cost data. In addition, there is little agreement across global vaccine development funders on which epidemic infectious disease investments should be prioritised, which stems from an absence of global research and development portfolio strategy and coordination.
MMR vaccinations resume in Samoa
20 NOV - Samoa's Health Ministry has resumed MMR vaccinations, after a moratorium was placed in the wake of the death of two toddlers in July.
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
19 NOV Via CIDRAP - The highly purified inactivated vaccine candidate, VLA1601, met the study’s primary endpoint showing a favorable safety profile in all doses and schedules tested.
VLA1601 was also immunogenic in all treatment groups and induced both dose- and schedule-dependent neutralizing antibodies against the Zika virus with the kinetics expected for an inactivated, alum-adjuvanted whole-virus vaccine.
Malaria parasite getting resistant to key drug
19 NOV Kalyan Ray - Artemisinin resistance was reported from South Asia and Africa in the past, India was so far free from the threat that has the potential to hit malaria eradication targets set by the government. Malarial parasite Plasmodium falciparum causes the most virulent form of malaria.
Britain, Indonesia Collaborate to Improve Medical Quality
18 NOV - Britain and Indonesia collaborated through Health Education workshops to improve the quality of medical personnel, especially for Indonesia, through cooperation and mutual exchange of inter-professional health experiences. Based on information from the British Embassy in Jakarta on Saturday, the Health Education workshop was held by several Indonesian and English institutions, namely the Department of International Trade of the British Embassy (DIT), the Young Indonesian Professional Health Community (IYHPS), and the Joint Research Ministry Committee Technology and Higher Education-Ministry of Health.
Looking beyond the Decade of Vaccines
17 NOV - When in 2010 the global health community declared the so-called Decade of Vaccines, it marked a path towards an ambitious vision for 2020: a world in which all individuals and communities enjoy lives free from vaccine-preventable diseases.
China reports new outbreaks of African swine fever in Jiangxi, Yunnan, Sichuan and Shanghai
17 NOV - Four new outbreaks of African swine fever have been reported in China’s provinces of Jiangxi, Yunnan and Sichuan as well as the municipality of Shanghai, the agriculture ministry said on Saturday.
Group of students aim to improve malaria diagnosis using old smartphones
16 NOV - Over 212 million cases of malaria are reported annually, with the majority of incidences occuring in Sub-Saharan Africa. However, a lack of medical resources means blood sample analysis is often delayed, leading to errors and ultimately high mortality rates. Seeking to improve the efficiency and accuracy of diagnosis, a group of students from Delft University of Technology are developing Excelscope, a semi-automated malaria diagnostic device.